307 related articles for article (PubMed ID: 23408461)
21. Primary Non-Function of Hepatic Allograft With Preexisting Microvesicular Steatosis/Foamy Degeneration and Mild Large-Droplet Macrovesicular Steatosis.
Limia ME; Liu XL; Yu J; Byrnes K
Gastroenterology Res; 2024 Feb; 17(1):37-40. PubMed ID: 38463149
[TBL] [Abstract][Full Text] [Related]
22. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation.
Ryan CK; Johnson LA; Germin BI; Marcos A
Liver Transpl; 2002 Dec; 8(12):1114-22. PubMed ID: 12474149
[TBL] [Abstract][Full Text] [Related]
23. Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study.
Gabrielli M; Moisan F; Vidal M; Duarte I; Jiménez M; Izquierdo G; Domínguez P; Méndez J; Soza A; Benitez C; Pérez R; Arrese M; Guerra J; Jarufe N; Martínez J
Ann Hepatol; 2012; 11(6):891-8. PubMed ID: 23109453
[TBL] [Abstract][Full Text] [Related]
24. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
[TBL] [Abstract][Full Text] [Related]
25. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index.
Lee SW; Park SH; Kim KW; Choi EK; Shin YM; Kim PN; Lee KH; Yu ES; Hwang S; Lee SG
Radiology; 2007 Aug; 244(2):479-85. PubMed ID: 17641368
[TBL] [Abstract][Full Text] [Related]
26. Use of steatotic graft in living-donor liver transplantation.
Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
[TBL] [Abstract][Full Text] [Related]
27. Is Unenhanced Computed Tomography Reliable in the Assessment of Macrovesicular Steatosis in Living Liver Donors?
Haberal KM; Turnaoğlu H; Haberal Reyhan AN
Exp Clin Transplant; 2019 Dec; 17(6):749-752. PubMed ID: 31666000
[TBL] [Abstract][Full Text] [Related]
28. Effect of graft steatosis on liver function and organ survival after liver transplantation.
Angele MK; Rentsch M; Hartl WH; Wittmann B; Graeb C; Jauch KW; Loehe F
Am J Surg; 2008 Feb; 195(2):214-20. PubMed ID: 18154767
[TBL] [Abstract][Full Text] [Related]
29. Body mass index as a predictor of hepatic steatosis in living liver donors.
Rinella ME; Alonso E; Rao S; Whitington P; Fryer J; Abecassis M; Superina R; Flamm SL; Blei AT
Liver Transpl; 2001 May; 7(5):409-14. PubMed ID: 11349260
[TBL] [Abstract][Full Text] [Related]
30. Discarded organs at Shiraz Transplant Center.
Shamsaeefar A; Nikeghbalian S; Kazemi K; Mansorian M; Gholami S; Motazedian N; Malekhosseini SA
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():178-81. PubMed ID: 24635823
[TBL] [Abstract][Full Text] [Related]
31. Hepatic steatosis in organ donors: disparity between surgery and histology?
Rey JW; Wirges U; Dienes HP; Fries JW
Transplant Proc; 2009; 41(6):2557-60. PubMed ID: 19715973
[TBL] [Abstract][Full Text] [Related]
32. Impact of a Full-Time Donor Management Protocol on Donors' Liver Biopsy Findings: Progress to Date.
Mojtabaee M; Shamsaeefar A; Gholami S; Mohsenzadeh M; Sadegh Beigee F
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):269-272. PubMed ID: 28260484
[TBL] [Abstract][Full Text] [Related]
33. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
[TBL] [Abstract][Full Text] [Related]
34. Donor liver dysfunction: application of a new scoring system to identify the marginal donor.
Ferraz-Neto BH; Zurstrassen MP; Hidalgo R; Fonseca LE; Motta TD; Pandullo FL; Rezende MB; Meira-Filho SP; Sá JR; Afonso RC
Transplant Proc; 2007 Oct; 39(8):2516-8. PubMed ID: 17954162
[TBL] [Abstract][Full Text] [Related]
35. Automated image analysis method for detecting and quantifying macrovesicular steatosis in hematoxylin and eosin-stained histology images of human livers.
Nativ NI; Chen AI; Yarmush G; Henry SD; Lefkowitch JH; Klein KM; Maguire TJ; Schloss R; Guarrera JV; Berthiaume F; Yarmush ML
Liver Transpl; 2014 Feb; 20(2):228-36. PubMed ID: 24339411
[TBL] [Abstract][Full Text] [Related]
36. Effects of the liver volume and donor steatosis on errors in the estimated standard liver volume.
Siriwardana RC; Chan SC; Chok KS; Lo CM; Fan ST
Liver Transpl; 2011 Dec; 17(12):1437-42. PubMed ID: 22127780
[TBL] [Abstract][Full Text] [Related]
37. Use of livers with microvesicular fat safely expands the donor pool.
Fishbein TM; Fiel MI; Emre S; Cubukcu O; Guy SR; Schwartz ME; Miller CM; Sheiner PA
Transplantation; 1997 Jul; 64(2):248-51. PubMed ID: 9256182
[TBL] [Abstract][Full Text] [Related]
38. High-grade microsteatosis and delay in hepatic function after orthotopic liver transplantation.
Sharkey FE; Lytvak I; Prihoda TJ; Speeg KV; Washburn WK; Halff GA
Hum Pathol; 2011 Sep; 42(9):1337-42. PubMed ID: 21420717
[TBL] [Abstract][Full Text] [Related]
39. Assessment of hepatic steatosis: comparison of quantitative and semiquantitative methods in 108 liver biopsies.
Turlin B; Ramm GA; Purdie DM; Lainé F; Perrin M; Deugnier Y; Macdonald GA
Liver Int; 2009 Apr; 29(4):530-5. PubMed ID: 19018987
[TBL] [Abstract][Full Text] [Related]
40. Effect of steatosis donor liver transplantation on hepatocellular carcinoma recurrence: experience at a single institution.
Teng da H; Zhu ZJ; Zheng H; Deng YL; Sun LY; Pan C; Liu YH; Song HL; Shen ZY
Hepatogastroenterology; 2012 May; 59(115):858-62. PubMed ID: 22389257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
